TNF and Crohn disease: Thus, the use of this technique has revealed a close relationship between ADCC activity and infliximab levels, determined using a specific ELISA and infliximab activity determined using a TNFα responsive reporter gene assay [23] in archival serum samples from patients with Crohn's disease.